Solutions

Academic research

Improve patient outcomes and advance health equity

Utilize real-world data, powerful analytics, and the Truveta Language Model for your research, with affordable pricing.

How we can help

Comparative effectiveness

Evaluate outcomes across diverse patient groups with complete, timely, and representative longitudinal data Compare disease progression and treatment across diverse patient groups 

  • Understand disease severity with access to complete EHR data
  • Evaluate long-term effectiveness with access to 5+ years of patient data
  • Uncover new insights across care settings and geographies
  • Control confounding variables with access to all comorbidities and granular clinical data

Comparing on-treatment weight loss and adverse events

Comparative bleeding incidence 7 days post-procedure for pulmonary embolism interventions

 Read the research

Epidemiology

Study disease determinants, prevalence, and distribution among populations using real-world data from 120M+ patients.

  • Track disease detection and treatment across unique populations with daily-updated data
  • Identify risk factors for emerging diseases from complete patient records
  • Monitor vaccine effectiveness and access to care across diverse populations
  • Evaluate the impact of public health interventions over time 
  • Analyze the impact of SDOH variables on healthcare access and outcomes

Analyze disease determinants, prevalence, and distribution across populations using real-world data from over 120M patients

Actual and predicted rates of speech delays across age groups

 Read the research

Clinical research

Uncover novel insights and support translational research from research-ready, representative data.

  • Analyze trends in disease prevention, progression and treatment
  • Identify trends for personalized treatment approaches
  • Discover variations in screening, diagnoses, and treatment across patient groups
  • Optimize study design and protocol by updating inclusion and exclusion criteria in real-time
  • Uncover adverse effects with daily updated data  

Uncovering trends in screenings for prostate-related conditions

PSA testing, prostate-specific antigen testing, EHR data, prostate cancer screeningDistribution of first-time PSA values by age group

 Read the research

Population health

Monitor disease trends and close care gaps with daily updated data

  • Perform real-time surveillance of screening, diagnoses, and treatment patterns 
  • Study patterns of disease incidence among demographic or clinical profiles
  • Monitor disease outbreaks and vaccine safety
  • Study maternal and pediatric health with access to more than 1 million mother-child pairs
  • Gauge the impact of policies on health outcomes

Monitoring respiratory virus-associated hospitalizations in real-time

Cumulative rate of weekly respiratory virus-associated hospitalizations compared to all hospital admissions

 Read the research

Care quality

Assess and deliver more equitable, high-quality care with insights from complete real-world data.

  • Design and validate new standards of care using granular clinical data
  • Compare quality indicators to a national population
  • Conduct studies assessing the long-term, real-world safety of different treatments 
  • Identify disparities and gaps in care across various patient populations
  • Guide evidence-based decisions by linking treatment patterns to outcomes

Exploring the impact of removing race as a diagnostic factor

Presented at ICPE 2024, Truveta Research explores the time to potassium-lowering drugs after removal of race from CKD-EPI creatinine equation.Changes in time to prescription of potassium-lowering drugs before and after the implementation of the race-free CKD-EPI 2021 creatinine equation


 Read the research

How we can help

Comparative effectiveness

Epidemiology

Clinical research

Population health

Care quality

Comparative effectiveness

Evaluate outcomes across diverse patient groups with complete, timely, and representative longitudinal data.

^

Compare disease progression and treatment across diverse patient groups

^

Understand disease severity with access to complete EHR data

^

Evaluate long-term effectiveness with access to 5+ years of patient data

^
Uncover new insights across care settings and geographies
^
Control confounding variables with access to all comorbidities and granular clinical data
Comparing on-treatment weight loss and adverse events
Comparison table from a scientific publication using Truveta Data to illustrate bleeding events associated with two medical devices for treating pulmonary embolism: the USCDT (Unspecified Superiority Clot Dissolver) and MT (Standard Mechanical Thrombectomy). The data is presented for two distinct time periods—2009 to 2023 (primary analysis) and 2018 to 2023 (contemporary analysis). Bleeding events are categorized into six types, with results presented as counts and percentages. Statistical significance is indicated by p-values, providing insights into the safety profiles of the two devices over time.
Mean percentage change in body weight at 3, 6, and 12 months receiving treatment for the overall population, those with type 2 diabetes (T2D), and those without T2D

Epidemiology

Study disease determinants, prevalence, and distribution among populations using real-world data from 120M+ patients.

^
Track disease detection and treatment across unique populations with daily-updated data
^
Identify risk factors for emerging diseases from complete patient records
^

Monitor vaccine effectiveness and access to care across diverse populations

^
Evaluate the impact of public health interventions over time
^
Analyze the impact of SDOH variables on healthcare access and outcomes
Analyze disease determinants, prevalence, and distribution across populations using real-world data from over 120M patients
October 2023 Respiratory Viruses hospitalizations trend report
Actual and predicted rates of speech delays across age groups

Clinical research

Uncover novel insights and support translational research from research-ready, representative data.

^
Analyze trends in disease prevention, progression, and treatment
^
Identify trends for personalized treatment approaches
^
Discover variations in screening, diagnoses, and treatment across patient groups
^
Optimize study design and protocol by updating inclusion and exclusion criteria in real-time
^
Uncover adverse effects with daily updated data
Uncovering trends in screenings for prostate-related conditions
PSA testing, prostate-specific antigen testing, EHR data, prostate cancer screening
Distribution of first-time PSA values by age group

Population health

Monitor disease trends and close care gaps with daily updated data

^
Perform real-time surveillance of screening, diagnoses, and treatment patterns
^
Study patterns of disease incidence among demographic or clinical profiles
^
Monitor disease outbreaks and vaccine safety
^
Study maternal and pediatric health with access to more than 1 million mother-child pairs
^

Gauge the impact of policies on health outcomes

Monitoring respiratory virus-associated hospitalizations in real-time
Truveta Research uses EHR data to explore trends in monthly respiratory virus-associated hospitalizations for RSV, COVID, influenza, parainfluenza, HMPV, and rhinovirus.
Cumulative rate of weekly respiratory virus-associated hospitalizations compared to all hospital admissions

Care quality

Assess and deliver more equitable, high-quality care with insights from complete real-world data.

^
Design and validate new standards of care using granular clinical data
^
Compare quality indicators to a national population
^
Conduct studies assessing the long-term, real-world safety of different treatments
^
Identify disparities and gaps in care across various patient populations
^
Guide evidence-based decisions by linking treatment patterns to outcomes 
Exploring the impact of removing race as a diagnostic factor
Presented at ICPE 2024, Truveta Research explores the time to potassium-lowering drugs after removal of race from CKD-EPI creatinine equation.
Changes in time to prescription of potassium-lowering drugs before and after the implementation of the race-free CKD-EPI 2021 creatinine equation

Why Truveta

Affordable pricing

Truveta offers flexible, affordable pricing for academic and research organizations without per-user license fees.

Complete, research-ready data

Truveta offers complete, timely, and clean EHR data linked with SDOH, mortality, and claims data for more than 120 million patients representing the full diversity of the US.

Powerful analytics

Truveta Studio provides immediate access to Truveta Data, powerful analytics, and the ability to dynamically test inclusion/exclusion criteria in real-time. 

Trusted by leading life science, public health, healthcare, and academic research organizations